Pharmacological Comparison of Continuous and Intermittent Infusions of Cloxacillin

NACompletedINTERVENTIONAL
Enrollment

12

Participants

Timeline

Start Date

November 23, 2017

Primary Completion Date

November 23, 2017

Study Completion Date

September 18, 2018

Conditions
InfectionMethicillin Susceptible Staphylococcus Aureus InfectionCloxacillin Treatment
Interventions
DRUG

Modification for administration mode of cloxacillin antibiotic

"For intermittent administration, patients will benefit from cloxacillin treatment in conventional hospitalization, in accordance with national guidelines, at a dose of 150 mg / kg per day in 4 infusions, not exceeding the maximum daily dose of 12 g / day according to.~For continuous administration the same quantity of cloxacillin 150 mg / kg per day, without exceeding the maximum daily dose of 12 g / day, will be delivered by a self-propelled syringe in twice 12 hours. Patients randomly assigned to receive continuous administration will receive a dose of cloxacillin equivalent to the dose administered 4 times daily during iterative administration using a self-pulsating syringe. For the first day of the study, this loading dose will be subtracted from the 150 mg / kg dose to be administered continuously over the remaining 23 hours of the first day of the study and never exceed 12g / day.~Pharmacological dosages will be performed on the third and sixth day in both arms"

Trial Locations (1)

Unknown

CHU de Nice, Nice

All Listed Sponsors
lead

Centre Hospitalier Universitaire de Nice

OTHER

NCT03246360 - Pharmacological Comparison of Continuous and Intermittent Infusions of Cloxacillin | Biotech Hunter | Biotech Hunter